# Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients

> **NCT04742816** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 42 (actual)

## Conditions studied

- Transgender
- Renal Function
- Hormone Replacement Therapy

## Interventions

- **DIAGNOSTIC_TEST:** IHX-CL measurements
- **DRUG:** Iohexol

## Key facts

- **NCT ID:** NCT04742816
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-17
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04742816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04742816, "Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04742816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*